Pharma under threat from bill to expand drug price negotiations

Shopping basket full of medicines, pills, blisters and vaccine on a receipt. Expensive medicine and healthcare concept.


Shopping basket full of medicines, pills, blisters and vaccine on a receipt. Expensive medicine and healthcare concept.

Bet_Noire/iStock via Getty Images

A recently introduced piece of legislation in the House that would allow drug price negotiations and inflation rebates on behalf of those with private insurance could potentially harm pharma companies’ bottom line.

The Lowering Drug Costs for American Families Act (H.R. 4895), introducedexpand drug cost relief measures

Leave a Reply

Your email address will not be published. Required fields are marked *